Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXVK1I
|
||||
| Drug Name |
(S)-N-(1-(2-(4-methoxy-3,5-dimethylphenylamino)ethylamino)-4-methyl-1-oxopentan-2-yl)-3-methylbenzamide
|
||||
| Synonyms |
CHEMBL379253
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H35N3O3
|
||||
| Canonical SMILES |
COc1c(C)cc(NCCNC(=O)[C@H](CC(C)C)NC(=O)c2cccc(C)c2)cc1C
|
||||
| InChI |
InChI=1S/C25H35N3O3/c1-16(2)12-22(28-24(29)20-9-7-8-17(3)13-20)25(30)27-11-10-26-21-14-18(4)23(31-6)19(5)15-21/h7-9,13-16,22,26H,10-12H2,1-6H3,(H,27,30)(H,28,29)/t22-/m0/s1
|
||||
| InChIKey |
YHDGNBGQARWTQO-QFIPXVFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.